Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

about

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

Item

http://www.wikidata.org/entity/Q38955195

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

@en

type

Item

label

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

@en

prefLabel

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

@en

P1476

Hydroxyurea in Sickle Cell Disease: Our Experience in Western India.

@en

P2093

Amey Koranne

http://www.w3.org/2001/XMLSchema#string

Ankit Patel

http://www.w3.org/2001/XMLSchema#string

Arpan Mehta

http://www.w3.org/2001/XMLSchema#string

Parth Desai

http://www.w3.org/2001/XMLSchema#string

S S Bhatwadekar

http://www.w3.org/2001/XMLSchema#string

S V Deshpande

http://www.w3.org/2001/XMLSchema#string

Shweta Khadse

http://www.w3.org/2001/XMLSchema#string

Tarang Bhavsar

http://www.w3.org/2001/XMLSchema#string

P2860

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease.

Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Hydroxyurea for the treatment of sickle cell anemia.

Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.

Deformability of oxygenated irreversibly sickled cells.

The presentation, management and prophylaxis of sickle cell disease.

Participation of hemoglobins A and F in polymerization of sickle hemoglobin.

Alpha-thalassemia in blacks: genetic and clinical aspects and interactions with the sickle hemoglobin gene.

P2888

s12288-015-0542-1

P304

215-220

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-015-0542-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27065586

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

4788998

http://www.w3.org/2001/XMLSchema#string